Proliferation financing: General information for Australian businesses
Tranche 2 expands AML/CTF obligations to include proliferation financing (PF) risks. This article provides general information about what PF means and how it relates to AML/CTF programs.
What is proliferation financing?
Proliferation financing refers to the act of providing funds or financial services that are used, in whole or in part, for the development, acquisition, manufacture, possession, transport, transfer, or use of nuclear, chemical, or biological weapons, their means of delivery, and related materials.
In simpler terms, it involves financial activity that supports the spread of weapons of mass destruction (WMDs).
International context
The inclusion of proliferation financing in AML/CTF frameworks reflects international standards set by the Financial Action Task Force (FATF). Australia has adopted these standards as part of its commitment to global financial crime prevention efforts.
Why PF matters under Tranche 2
Under the AML/CTF Amendment Act 2024, reporting entities are required to identify, mitigate and manage not just money laundering (ML) and terrorism financing (TF) risks, but also proliferation financing (PF) risks. This is often referred to as "ML/TF/PF" throughout the legislation and regulatory guidance.
For businesses affected by Tranche 2, this means:
- Risk assessments typically consider PF alongside ML and TF
- AML/CTF programs generally address all three risk types
- Sanctions screening may include checks against proliferation-related lists
- Suspicious matter reporting may include PF-related concerns
Sanctions connection
Australia maintains sanctions regimes that target proliferation activities. These sanctions are administered by the Department of Foreign Affairs and Trade (DFAT) and may include:
- Targeted financial sanctions against designated individuals and entities
- Country-specific sanctions programs
- UN Security Council sanctions
Businesses may consider sanctions screening as part of their approach to managing PF risk. The DFAT Consolidated List includes designations related to weapons proliferation.
Questions businesses may consider
When thinking about proliferation financing in the context of your AML/CTF program, some questions to consider discussing with your adviser include:
- How does PF risk apply to my specific designated services?
- What sanctions lists are relevant to my business?
- How should I document PF considerations in my risk assessment?
- What screening processes are appropriate for my customer base?
- How do I recognise potential PF red flags in my sector?
- What training should staff receive about PF risks?
Documentation considerations
Businesses commonly address PF in their AML/CTF documentation in the following ways:
Risk assessment
Including PF as a risk category alongside ML and TF, assessing relevance to designated services
Compliance procedures
Documenting any sanctions screening procedures and how PF concerns would be escalated
Training materials
Including PF awareness as part of staff AML/CTF training
Further resources
For official information about proliferation financing and Australia's sanctions regime, refer to:
Official Australian sanctions information
AUSTRACAML/CTF regulatory guidance
FATF Proliferation FinancingInternational standards and guidance
Read our complete Tranche 2 Guide
Key dates, affected sectors, obligations and how to prepare
Start your documentation efficiently
HeadStart Docs™ free compliance documents include ML/TF/PF risk assessment frameworks. All documents require legal review and tailoring.
Disclaimer: This article is general information only. It is not legal, financial or compliance advice. HeadStart Docs™ provides free compliance documents, not legal services.
We do not guarantee the accuracy of information provided. Obligations may apply depending on your designated services. Always confirm your specific requirements with a qualified adviser.
Need a lawyer to review your AML/CTF program? HeadStart Counsel offers fixed-fee tailoring from $1,800+GST. Separate entity and engagement.


